Buteyko Breathing Method - Clinical Trials |
S.No. |
Clinical Trials |
Year |
Result |
1 |
Calgary, Canada. Pubmed |
2008 |
a. Substantial improvement to quality of life
b. 41% reduction of inhaled corticosteroid
c. 41% reduction of long acting beta agonist
d. Improved control of 79% |
2 |
The New Zealand Medical Journal |
2003 |
a. 85% decrease in use Bronchodilators at 6 months
b. 50% decrease in use of Inhaled Steroids at 6 months |
3 |
Buteyko trial for children – New Zealand Medical Journal |
2003 |
a. 66% decrease in use Bronchodilators at 6 months
b. 41% decrease in use of Inhaled Steroids at 6 months |
4 |
Strathclyde Trials (600 Patients) |
2001 |
a. British Thoracic Society/ Thorax Buteyko Strathclyde trials
b. 98% of group had reduced asthma symptoms-coughing, wheezing, breathlessness
c. 98% of group had reduced need for reliever medication
d. 92% of group had reduced need for inhaled preventer medication
e. 96% of group had reduced need for oral preventer medication |
5 |
Clinical Trial of Buteyko as taught by video Pubmed |
2000 |
Our results demonstrated a significant improvement in quality of life among those assigned to the BBT compared with placebo (p = 0.043), as well as a significant reduction in inhaled bronchodilator intake (p = 0.008). |
6 |
Mater Hospital Brisbane Medical Journal Australia |
1998 |
a. 90% decrease in use Bronchodilators at 3 months
b. 49% decrease in use of Inhaled Steroids at 3 months
c. 71% improvement of Symptoms Score at 3 months
d. 54% improvement in Quality of life at 6 weeks |
